TROG Cancer Research
Members Login   CQMS Login  

Search by trial number

Trials in development (starting soon)

This phase commences when a new proposal is approved for development by the TSC.

TD 17.05 (AZTEC) Breast
TD 17.01 (DESSERT) Lung
TD 13.03 (SABR-OS) Lung
TROG 16.02 (LOCAL HER-O) Breast
TROG 15.02 (ROAM) Meningioma
TROG 14.04 (HART) Breast

Open trials

A trial is considered as open (to accrual) when the first Trial Site has submitted all required regulatory and ethical documentation and has been approved for activation by the Trial Coordinating Centre.

TROG 16.03 (CORE) Breast, Lung and Prostate
TROG 16.01 (NIVORAD) Lung
TROG 15.03 (FASTRACK II) Kidney
TROG 15.01 (SPARK) Prostate
TROG 14.03 (EORTC 1219) Head & neck
TROG 14.02 (RAIDER) Bladder
ANZUP 1303 (ENZARAD) Prostate
TROG 13.01 (SAFRON II) Lung
TROG 12.02 (PET LABRADOR) Breast
TROG 12.01 (HPV) Head & neck
TROG 11.03 (P_LUNG) Lung
TROG 08.09 (RTN2) Skin
TROG 08.08 (TOP GEAR) Gastrointestinal
TROG 08.05 (WBRT Mel) Central nervous system

Trials closed to accrual

A trial is considered closed to accrual after the last patient has been recruited. Patients will be in follow up.

TROG 11.01 (SUPREMO) Breast
TROG 10.02 (RAPID) Breast
TROG 09.03 (MP3) Skin
TROG 08.06 (STARS) Breast
TROG 08.04 (PORTEC3) Gynaecological
TROG 08.03 (RAVES) Prostate
TROG 07.01 (DCIS) Breast
TROG 06.02 (APBI) Breast
TROG 06.01 Central nervous system
TROG 03.04 (RADAR) Prostate
TROG 99.03 Lymphoma

Trials closed to follow-up

During the closed to follow-up phase the main analyses will occur and processes implemented to complete the trial.

TROG 12.03 (EAT) Head & neck
TROG 11.02 (SCORAD III) Symptom Management
TROG 09.02 (CHISEL) Lung
TROG 09.01 (PROArCT) Gastrointestinal
TROG 08.02 (GBM in elderly patients) Central nervous system
TROG 08.01 (PROFIT) Prostate
TROG 07.04 Head & neck
TROG 07.03 (RadioHum) Head & neck
TROG 05.02 (MALT Lymphoma) Lymphoma
TROG 05.01 (POST) Head & neck
TROG 03.05 (MA20) Breast
TROG 03.03 (HDNLHL4) Lymphoma
TROG 03.01 Gastrointestinal
TROG 02.03 Bladder
TROG 01.02 Lymphoma

Completed trials

A trial is considered to be completed when all analyses have been performed and published, the trial database has been locked, trial sites have been closed and records archived.

All completed trials

We are thankful to our 14,000 patients who have participated in our research. Please continue the generous support.